Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124877352 | 12487735 | 2 | F | 20160628 | 20160622 | 20160712 | EXP | US-AUROBINDO-AUR-APL-2016-08166 | AUROBINDO | LEE JJ, ET AL. LOPERAMIDE QTC PROLONGATION AND WIDE QRS: CASE REPORT. REACTIONS WEEKLY. 2016;1607:263 | 25.00 | YR | M | Y | 0.00000 | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124877352 | 12487735 | 1 | PS | Loperamide | LOPERAMIDE | 1 | Oral | 300 MG, DELIBERATELY INGESTED 300 MG OF LOPERAMIDE | U | 206548 | 300 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124877352 | 12487735 | 1 | Euphoric mood |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124877352 | 12487735 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124877352 | 12487735 | Arrhythmia | |
| 124877352 | 12487735 | Electrocardiogram QRS complex prolonged | |
| 124877352 | 12487735 | Electrocardiogram QT prolonged | |
| 124877352 | 12487735 | Intentional overdose | |
| 124877352 | 12487735 | Mental status changes | |
| 124877352 | 12487735 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |